The safety of antibiotic skin testing in severe T-cell-mediated hypersensitivity of immunocompetent and immunocompromised hosts

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1341-1343.e1. doi: 10.1016/j.jaip.2018.09.014. Epub 2018 Sep 26.

¹ Department of Infectious Diseases and Centre for Antibiotic Allergy and Research, Austin Health, VIC, Heidelberg, Australia; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Department of Medicine (Austin Health), University of Melbourne, Heidelberg, VIC, Australia; The National Centre for Infections in Cancer, Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Electronic address: jason.trubiano@austin.org.au.
² Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; The National Centre for Infections in Cancer, Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
³ Department of Dermatology, Austin Health, Heidelberg, VIC, Australia; Department of Dermatology, Alfred Health, Heidelberg, VIC, Australia.
⁴ Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia; Department of Medicine, Vanderbilt University Medical Centre, Nashville, Tenn.

No abstract available

Publication types